|
SFRS13B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62492241884138E-12 |
| Normal-vs-Stage2 |
9.435000E-04 |
| Normal-vs-Stage3 |
1.979170E-04 |
| Normal-vs-Stage4 |
1.283570E-02 |
| Stage1-vs-Stage2 |
8.427400E-01 |
| Stage1-vs-Stage3 |
7.224600E-01 |
| Stage1-vs-Stage4 |
3.756400E-01 |
| Stage2-vs-Stage3 |
9.327400E-01 |
| Stage2-vs-Stage4 |
5.869400E-01 |
| Stage3-vs-Stage4 |
6.322000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
6.58379994966651E-09 |
| Normal-vs-Asian |
5.236000E-01 |
| Caucasian-vs-AfricanAmerican |
3.602800E-01 |
| Caucasian-vs-Asian |
1.470220E-01 |
| AfricanAmerican-vs-Asian |
2.106400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.53129739391511E-11 |
| Male-vs-Female |
1.812090E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.2420000000144E-06 |
| Normal-vs-Extreme_Weight |
2.3890001088489E-10 |
| Normal-vs-Obese |
3.43249983991711E-10 |
| Normal-vs-Extreme_Obese |
3.063600E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.318000E-01 |
| Normal_Weight-vs-Obese |
8.561000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.926200E-01 |
| Extreme_Weight-vs-Obese |
1.342780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.907000E-01 |
| Obese-vs-Extreme_Obese |
8.974400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.383830E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
2.84672285744136E-12 |
| Normal-vs-Age(81-100Yrs) |
1.878030E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.493000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.075600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.604400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.258200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.583800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.594000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.011900E-04 |
| Normal-VS-KIRP CIMP |
1.027910E-02 |
| Normal-VS-Unclassified PRCC |
3.192800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.60698999999154E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.695800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.059500E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.470400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.686400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.449600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.61869999998543E-06 |
| Normal-vs-N1 |
3.71639999999784E-05 |
| Normal-vs-N2 |
1.481970E-01 |
| N0-vs-N1 |
1.802340E-02 |
| N0-vs-N2 |
9.354600E-01 |
| N1-vs-N2 |
3.139000E-01 |
|
|
